Testosterone Aromatization to Estradiol in Course of Ovarian Functioning Brenner Tumor Associated With Endometrial Carcinoma and Endometriosis (Roncati-Manenti Triad)
article
OA: green
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study identified a rare triad of ovarian Brenner tumor, endometrial carcinoma, and endometriosis in postmenopausal women, finding high testosterone in the tumor and high estrogen/progesterone in the other tissues.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveAromatization is the biochemical process in which aromatase catalyzes the conversion of testosterone into estradiol, the fundamental pathway for the synthesis of estrogens. When enhanced, it can lead to hyperestrogenism, a well-known risk factor for gynecological cancers.MethodsThe surgical specimens, coming from 2 postmenopausal women with hyperestrogenism on pap smear and bioptic diagnosis of endometrial endometrioid carcinoma, were fixed in 10% neutral buffered formalin, paraffin embedded, and then submitted for routine hematoxylin/eosin staining and immunohistochemical characterization for antiestrogen, antiprogesterone, antitesterone, anti-MLH1, anti-PMS2, anti-MSH2, and anti-MSH6.ResultsThe presence of an undescribed triad represented by ovarian functioning Brenner tumor, endometrial carcinoma, and pelvic endometriosis has been ascertained. The immunohistochemical investigation proved a normal expression of the DNA mismatch repair proteins and revealed a bimodal hormonal status in the pathological tissues, that is, the Brenner tumor cells showed a high expression of testosterone, contrariwise endometrioid carcinoma and endometriosis a high estrogen and progesterone immunolabeling.ConclusionsThis synchronous triad underlines the importance of aromatization and hyperestrogenism in the development of gynecological malignancies in which the immunohistochemical detection of an active source of hormone production - to always keep in consideration during synchronous diseases - can guide subsequent antihormone chemotherapy based on aromatase inhibitors.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (18)
- W140092851 via openalex
- W185549381 via openalex
- W1975203448 via openalex
- W1976605645 via openalex
- W2018210095 via openalex
- W2023009163 via openalex
- W2049689871 via openalex
- W2069539467 via openalex
- W2094852647 via openalex
- W2126275169 via openalex
- W2134576998 via openalex
- W2290636298 via openalex
- W2317867663 via openalex
- W4249242318 via openalex
- W6605598703 via openalex
- W6696403611 via openalex
- W6698097258 via openalex
- W6716745507 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-09-11T06:15:56.568227+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:20:54.390225+00:00
License: CC0
· commercial use OK